Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_19616 | 70 | 1.46 | Mlig455_045100 | Neo: - Age: - |
RPH3A | Mlig455_045100 {REF} {Length: 2276} {Pfam: C2 domain [PF00168.32, score=141.3]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=247, Expect=9e-73]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=244, Expect=9e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=179, Expect=2e-50]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=209, Expect=6e-58]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=216, Expect=3e-62]} {RNA1310_30378} {RNA815_36857} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 0.299 | 1.722 | 0.99982 | 1.00000 | |
RegionR2 | 2.888 | 1.722 | 0.07024 | 0.32271 | |
RegionR3 | -0.759 | 1.722 | 0.91133 | 1.00000 | |
RegionR4 | -0.256 | 1.722 | 0.88363 | 1.00000 | |
RegionR5 | 0.99 | 1.722 | 0.33948 | 0.68639 | |
RegionR6 | -1.703 | 1.722 | 0.97632 | 1.00000 | |
RegionR7 | 1.201 | 1.722 | 0.45575 | 1.00000 | |
RegionR8 | -2.66 | 1.722 | 0.99956 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -3.635 | 1.722 | 0.99983 | 1.00000 | |
RegenerationR2 | -1.238 | 1.722 | 0.00457 | 0.10436 | |
RegenerationR3 | 0.311 | 1.722 | 0.83544 | 0.99242 | |
RegenerationR4 | -0.98 | 1.722 | 0.68140 | 0.94607 | |
RegenerationR5 | -2.209 | 1.722 | 0.00892 | 0.17058 | |
RegenerationR6 | 1.076 | 1.722 | 0.41860 | 0.74992 | |
RegenerationBL | 0.829 | 1.722 | 0.60023 | 0.94712 | |
RegenerationTP | 1.253 | 1.722 | 0.57783 | 0.94825 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_19616 | 70 | 1.46 | Mlig455_045100 | Neo: - Age: - |
RPH3A | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_045100 {REF} {Length: 2276} {Pfam: C2 domain [PF00168.32, score=141.3]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=247, Expect=9e-73]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=244, Expect=9e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [Score=179, Expect=2e-50]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=209, Expect=6e-58]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=216, Expect=3e-62]} {RNA1310_30378} {RNA815_36857} |
2. | MligTC455_19329 | 90 | 1.88 | Mlig455_068578 | Neo: - Age: - Region-enriched R2: 3.988/0.02701 |
CHAT | 5.42 | 0.967 | 0.879 | 0.913 | 0.885 | 0.859 | 0.917 | Mlig455_068578 {REF} {Length: 3661} {TRANSSPLICED} {Pfam: Choline/Carnitine o-acyltransferase [PF00755.22, score=556.7]} {Human: ENSG00000070748, CHAT, choline O-acetyltransferase, [RH, Score=519, Expect=2e-177]} {Mouse: ENSMUSG00000021919, Chat, choline acetyltransferase, [RH, Score=520, Expect=7e-178]} {Dmel: FBgn0000303, ChAT, Choline acetyltransferase, [RH, Score=488, Expect=1e-164]} {Celegans: WBGene00000481, cha-1, Choline O-acetyltransferase, [RH, Score=363, Expect=2e-117]} {Smed: dd_Smed_v6_6208_0_1, dd_Smed_v6_6208_0_1, [RH, Score=601, Expect=0.0]} {RNA1509_36058} {RNA1310_3092, RNA1509_36058} {RNA1509_36058, RNA815_2435.1} |
3. | MligTC455_31031 | 361 | 7.53 | Mlig455_009779 | Neo: - Age: - Region-enriched R2: 2.821/0.00350 |
LRRN3 | 5.336 | 0.731 | 0.963 | 0.858 | 0.954 | 0.900 | 0.930 | Mlig455_009779 {REF} {Length: 3647} {Pfam: Immunoglobulin domain [PF13927.8, score=35.5]; Immunoglobulin I-set domain [PF07679.18, score=34.5]; Immunoglobulin domain [PF00047.27, score=29.1]; Apolipoprotein A1/A4/E domain [PF01442.20, score=19.2]} {Human: ENSG00000173114, LRRN3, leucine rich repeat neuronal 3, [Score=56.2, Expect=2e-07]} {Dmel: FBgn0032479, CG16974, [RH, Score=116, Expect=3e-26]} {RNA1509_10344} {RNA1310_3046.1} {RNA815_12103} |
4. | MligTC455_21033 | 1129 | 23.52 | Mlig455_010672 | Neo: - Age: logFC(26M/2M)=0.356 Region-specific R2: 3.326 Region-enriched R2: 2.739/0.00000 Regeneration-downregulated R2: -1.967 Regeneration-depleted R2: -1.967 |
5.25 | 0.950 | 0.722 | 0.919 | 0.917 | 0.837 | 0.905 | Mlig455_010672 {REF} {Length: 829} {RNA1509_30331, RNA1509_45731} {RNA1310_60944, RNA1509_30331, RNA1509_45731} {RNA1509_30331, RNA1509_45731, RNA815_27381.1} | |
5. | MligTC455_20350 | 434 | 9.05 | Mlig455_002780, Mlig455_066934 | Neo: - Age: - Region-enriched R2: 3.513/0.00619 |
SYT12 | 5.196 | 0.716 | 0.946 | 0.894 | 0.959 | 0.972 | 0.709 | Mlig455_002780 {REF} {Length: 2380} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=207, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=3e-72]} {RNA1310_10982.1} {RNA815_10652.1} Mlig455_066934 {REF} {Length: 2274} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=206, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=2e-72]} {RNA1310_10982.1} {RNA815_10652.1} |
6. | MligTC455_33772 | 104 | 2.17 | Mlig455_016493 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.862/0.00025 |
5.151 | 0.908 | 0.716 | 0.743 | 0.878 | 0.970 | 0.936 | Mlig455_016493 {REF} {Length: 883} {RNA1310_43848} {RNA815_55624} | |
7. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
4.672 | 0.946 | 0.981 | 0.858 | 0.975 | 0.912 | - | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
8. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
4.574 | 0.973 | 0.894 | 0.830 | 0.912 | 0.965 | - | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
9. | MligTC455_29317 | 89 | 1.85 | Mlig455_062533 | Neo: - Age: logFC(26M/2M)=0.866 |
SLC18A3 | 4.535 | 0.868 | 0.832 | 0.917 | 0.945 | 0.973 | - | Mlig455_062533 {REF} {Length: 3319} {Pfam: Major Facilitator Superfamily [PF07690.18, score=140.0]; LacY proton/sugar symporter [PF01306.21, score=22.0]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=457, Expect=1e-155]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=462, Expect=8e-158]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=512, Expect=6e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=474, Expect=6e-163]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=535, Expect=0.0]} {RNA1509_22907} {RNA1310_5498.1, RNA1509_22907} {RNA1509_22907, RNA815_3951} |
10. | MligTC455_21182 | 238 | 4.96 | Mlig455_000068, Mlig455_063733 | Neo: - Age: Down-Up-Up Region-enriched R4: 5.301/0.04587 |
4.519 | 0.943 | 0.980 | 0.737 | 0.943 | 0.916 | - | Mlig455_000068 {REF} {Length: 468} {Pfam: Pancreatic hormone peptide [PF00159.20, score=23.7]} {RNA1310_81800.1} {RNA815_55075} Mlig455_063733 {REF} {Length: 531} {Pfam: Pancreatic hormone peptide [PF00159.20, score=20.7]} {RNA1310_81800.1} {RNA815_55075} |
|
11. | MligTC455_27799 | 414 | 8.62 | Mlig455_004285, Mlig455_004370 | Neo: - Age: Down-Up-Down Region-specific R2: 3.850 Region-enriched R2: 5.047/0.00000 |
4.475 | 0.953 | 0.782 | 0.891 | 0.872 | 0.977 | - | Mlig455_004285 {REF} {Length: 650} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} Mlig455_004370 {REF} {Length: 1653} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} |
|
12. | MligTC455_50844 | 224 | 4.67 | Mlig455_018511 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.591/0.00005 |
SSUH2 | 4.475 | 0.977 | 0.735 | 0.945 | 0.901 | 0.917 | - | Mlig455_018511 {REF} {Length: 1843} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=120, Expect=2e-29]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=95.5, Expect=3e-21]} {RNA1509_39980} {RNA1310_60742, RNA1509_39980} {RNA1509_39980, RNA815_28938} |
13. | MligTC455_16476 | 126 | 2.63 | Mlig455_042936 | Neo: - Age: - Region-enriched R2: 3.045/0.04509 |
4.455 | 0.928 | - | 0.971 | 0.721 | 0.932 | 0.903 | Mlig455_042936 {REF} {Length: 2571} {Pfam: Innexin [PF00876.20, score=347.0]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=102, Expect=9e-24]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=280, Expect=3e-91]} {Smed: dd_Smed_v6_10567_0_1, dd_Smed_v6_10567_0_1, [RH, Score=498, Expect=8e-177]} {RNA1509_13614} {RNA1310_14284} {RNA815_5221} | |
14. | MligTC455_19328 | 99 | 2.06 | Mlig455_062531 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.972/0.00232 |
4.45 | 0.950 | 0.872 | 0.917 | 0.742 | 0.969 | - | Mlig455_062531 {REF} {Length: 1929} {NoTransDecoderORF} {RNA1509_36058} {RNA1310_3092} {RNA815_16673} | |
15. | MligTC455_50362 | 295 | 6.16 | Mlig455_012011 | Neo: - Age: logFC(26M/2M)=1.080 Region-enriched R2: 3.396/0.00236 |
4.392 | 0.775 | 0.986 | - | 0.969 | 0.873 | 0.789 | Mlig455_012011 {REF} {Length: 947} {RNA1509_58656} {RNA1310_57201.1} {RNA815_30531.1} | |
16. | MligTC455_44712 | 665 | 13.86 | Mlig455_017186 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.471 Region-specific R2: 4.141 Region-enriched R2: 3.536/0.00000 |
4.38 | 0.730 | 0.986 | 0.814 | 0.960 | 0.890 | - | Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
17. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 4.371 | 0.962 | 0.724 | 0.941 | 0.865 | 0.879 | - | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
18. | MligTC455_54305 | 43 | 0.89 | Mlig455_035878, Mlig455_035917 | Neo: - Age: - |
ZC3H10 | 4.363 | 0.930 | - | 0.872 | 0.956 | 0.902 | 0.703 | Mlig455_035878 {REF} {Length: 2474} {tRNA: Val(CAC),pseudo, score=28.9} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} Mlig455_035917 {REF} {Length: 2428} {tRNA: Val(CAC),pseudo, score=30.2} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=25.6]; CCCH-type zinc finger [PF18044.3, score=20.1]; Zinc-finger containing family [PF15663.7, score=19.3]; Mediator complex subunit 3 fungal [PF11593.10, score=18.0]} {Human: ENSG00000135482, ZC3H10, zinc finger CCCH-type containing 10, [Score=149, Expect=2e-40]} {Mouse: ENSMUSG00000039810, Zc3h10, zinc finger CCCH type containing 10, [Score=149, Expect=2e-40]} {Smed: dd_Smed_v6_7175_0_2, dd_Smed_v6_7175_0_2, [Score=119, Expect=4e-29]} {RNA1509_47157} {RNA1310_87786} {RNA815_46414} |
19. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 4.34 | 0.744 | 0.773 | 0.931 | 0.954 | 0.938 | - | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
20. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
4.339 | 0.778 | 0.875 | 0.850 | 0.970 | 0.866 | - | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
21. | MligTC455_26652 | 30 | 0.63 | Mlig455_036452 | Neo: - Age: - |
NR2E1 | 4.256 | 0.820 | 0.841 | 0.897 | 0.736 | 0.962 | - | Mlig455_036452 {REF} {Length: 2848} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=99.9]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=55.3]} {Human: ENSG00000112333, NR2E1, nuclear receptor subfamily 2 group E member 1, [Score=139, Expect=2e-35]} {Mouse: ENSMUSG00000019803, Nr2e1, nuclear receptor subfamily 2, group E, member 1, [Score=139, Expect=1e-35]} {Dmel: FBgn0015381, dsf, dissatisfaction, [Score=129, Expect=6e-31]} {Celegans: WBGene00021417, nhr-236, Nuclear Hormone Receptor family, [RH, Score=135, Expect=1e-35]} {Smed: dd_Smed_v6_25420_0_1, dd_Smed_v6_25420_0_1, [RH, Score=182, Expect=3e-50]} {RNA1310_57853} {RNA815_57699} |
22. | MligTC455_43259 | 1085 | 22.6 | Mlig455_046108, Mlig455_070524 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.492 Region-enriched R2: 2.622/0.00302 |
4.25 | 0.723 | 0.780 | - | 0.956 | 0.941 | 0.850 | Mlig455_046108 {REF} {Length: 2758} {RNA1509_37301, RNA1509_56690} {RNA1310_56474, RNA1509_56690} {RNA1509_56690, RNA815_28702} Mlig455_070524 {REF} {Length: 2772} {RNA1509_37301} {RNA1310_56474, RNA1509_37301} {RNA1509_37301, RNA815_28702} |
|
23. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
4.227 | 0.777 | 0.818 | 0.797 | 0.951 | 0.884 | - | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
24. | MligTC455_16329 | 1019 | 21.23 | Mlig455_007993 | Neo: - Age: - Region-specific R2: 3.685 Region-enriched R2: 3.576/0.00000 |
4.21 | 0.730 | 0.837 | 0.778 | 0.962 | 0.903 | - | Mlig455_007993 {REF} {Length: 635} {RNA1509_22236} {RNA1310_84275, RNA1509_22236} {RNA1509_22236, RNA815_43046} | |
25. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
4.197 | 0.951 | 0.760 | 0.719 | 0.878 | 0.889 | - | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
26. | MligTC455_47792 | 666 | 13.88 | Mlig455_041913 | Neo: - Age: - Region-specific R2: 4.721 Region-enriched R2: 5.442/0.00000 |
4.192 | 0.861 | 0.767 | 0.825 | 0.951 | 0.788 | - | Mlig455_041913 {REF} {Length: 603} {RNA1509_14790} {RNA1310_58119} {RNA815_32986} | |
27. | MligTC455_35739 | 91 | 1.9 | Mlig455_050779 | Neo: - Age: Up-Down-Down |
ADGRL2 | 4.177 | 0.793 | 0.872 | 0.722 | 0.827 | 0.963 | - | Mlig455_050779 {REF} {Length: 4277} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=110.1]; Pentaxin family [PF00354.19, score=43.4]; Hormone receptor domain [PF02793.24, score=35.9]; Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=33.0]; GPCR-Autoproteolysis INducing (GAIN) domain [PF16489.7, score=20.5]; Myc amino-terminal region [PF01056.20, score=18.8]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=140, Expect=5e-33]; ENSG00000072071, ADGRL1, adhesion G protein-coupled receptor L1, [RH, Score=139, Expect=2e-32]; ENSG00000150471, ADGRL3, adhesion G protein-coupled receptor L3, [RH, Score=133, Expect=9e-31]} {Mouse: ENSMUSG00000028184, Adgrl2, adhesion G protein-coupled receptor L2, [RH, Score=142, Expect=1e-33]; ENSMUSG00000013033, Adgrl1, adhesion G protein-coupled receptor L1, [RH, Score=140, Expect=6e-33]} {Celegans: WBGene00002252, lat-2, Latrophilin-like protein LAT-2, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_16446_0_2, dd_Smed_v6_16446_0_2, [RH, Score=444, Expect=1e-139]} {RNA1509_25495} {RNA1310_3070} {RNA815_2153} |
28. | MligTC455_16209 | 72 | 1.51 | Mlig455_020329 | Neo: - Age: - Region-enriched R2: 5.444/0.00658 |
4.135 | 0.925 | 0.722 | 0.714 | 0.808 | 0.966 | - | Mlig455_020329 {REF} {Length: 2483} {Pfam: TIR domain [PF13676.8, score=38.4]; TIR domain [PF01582.22, score=29.5]; Domain of unknown function (DUF4481) [PF14800.8, score=20.4]} {Dmel: FBgn0032095, Toll-4, [RH, Score=53.1, Expect=7e-07]} {Smed: dd_Smed_v6_14454_0_1, dd_Smed_v6_14454_0_1, [RH, Score=270, Expect=2e-82]} {RNA1310_32445} {RNA815_27719} | |
29. | MligTC455_09510 | 314 | 6.55 | Mlig455_001134, Mlig455_042048 | Neo: - Age: - Region-specific R2: 5.291 Region-enriched R2: 5.151/0.00029 |
3.761 | 0.945 | - | 0.957 | 0.938 | 0.921 | - | Mlig455_001134 {REF} {Length: 485} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=26.9]} {RNA1310_8738.1} {RNA815_21682.1} Mlig455_042048 {REF} {Length: 1550} {Pfam: Fingers domain of DNA polymerase lambda [PF10391.11, score=32.1]} {Dmel: FBgn0036416, CG7924, [RH, Score=61.2, Expect=1e-10]} {RNA1509_51261} {RNA1310_8738.1} {RNA815_21682.1} |
|
30. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
3.716 | 0.950 | - | 0.890 | 0.962 | 0.914 | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
31. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
3.704 | 0.931 | - | 0.967 | 0.909 | 0.897 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
32. | MligTC455_34524 | 155 | 3.22 | Mlig455_021291 | Neo: - Age: Down-Up-Down Region-specific R2: 4.905 Region-enriched R2: 4.200/0.01842 |
3.704 | 0.964 | 0.895 | 0.940 | 0.905 | - | - | Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718} | |
33. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
3.7 | 0.944 | - | 0.959 | 0.872 | 0.925 | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
34. | MligTC455_12102 | 59 | 1.23 | Mlig455_041538, Mlig455_053099 | Neo: - Age: - Region-enriched R2: 6.626/0.00371 |
DEGS2 | 3.672 | 0.961 | - | 0.924 | 0.966 | 0.821 | - | Mlig455_041538 {REF} {Length: 1966} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.6]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=5e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=308, Expect=2e-103]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=6e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=5e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=4e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=7e-143]} {RNA1310_20672.2} {RNA815_19986} Mlig455_053099 {REF} {Length: 2009} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.5]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=4e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=309, Expect=7e-104]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=5e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=4e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=3e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=4e-143]} {RNA1310_20672.1} {RNA815_19986} |
35. | MligTC455_14598 | 52 | 1.07 | Mlig455_058970 | Neo: - Age: - |
3.67 | - | 0.782 | 0.947 | 0.972 | 0.969 | - | Mlig455_058970 {REF} {Length: 1038} {RNA1310_39570} {RNA815_52309} | |
36. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
3.67 | 0.961 | 0.949 | 0.954 | 0.806 | - | - | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
37. | MligTC455_33280 | 127 | 2.64 | Mlig455_010523 | Neo: - Age: Down-Up-Up |
3.666 | 0.943 | - | 0.872 | 0.970 | 0.881 | - | Mlig455_010523 {REF} {Length: 587} {RNA1509_48963} {RNA1310_65789} {RNA815_23468} | |
38. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
3.666 | 0.865 | - | 0.961 | 0.904 | 0.936 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
39. | MligTC455_38682 | 102 | 2.12 | Mlig455_039641 | Neo: - Age: - Region-enriched R2: 6.138/0.02363 |
SLC18A3 | 3.655 | 0.974 | 0.994 | 0.966 | - | 0.721 | - | Mlig455_039641 {REF} {Length: 3925} {Pfam: Major Facilitator Superfamily [PF07690.18, score=147.1]; Sugar (and other) transporter [PF00083.26, score=29.0]; LacY proton/sugar symporter [PF01306.21, score=20.2]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=469, Expect=9e-161]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=469, Expect=1e-160]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=513, Expect=2e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=486, Expect=2e-167]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_28397} {RNA815_32284.1} |
40. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
3.653 | 0.948 | 0.952 | - | 0.884 | 0.869 | - | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
41. | MligTC455_34655 | 89 | 1.86 | Mlig455_058020, Mlig455_058176 | Neo: - Age: - Region-enriched R2: 5.798/0.00826 |
PPEF1 | 3.629 | 0.882 | 0.965 | 0.813 | 0.969 | - | - | Mlig455_058020 {REF} {Length: 3007} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=84.9]; EF-hand domain pair [PF13499.8, score=77.8]; EF hand [PF00036.34, score=66.0]; EF-hand domain pair [PF13833.8, score=52.1]; EF-hand domain [PF13405.8, score=48.4]; EF hand [PF13202.8, score=38.2]; PPP5 TPR repeat region [PF08321.14, score=37.0]; EF-hand domain [PF14658.8, score=23.0]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=20.4]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [Score=416, Expect=2e-138]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=413, Expect=9e-138]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=404, Expect=3e-134]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=455, Expect=2e-155]} {Smed: dd_Smed_v6_11874_0_2, dd_Smed_v6_11874_0_2, [Score=516, Expect=2e-178]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} Mlig455_058176 {REF} {Length: 3371} {Pfam: Calcineurin-like phosphoesterase [PF00149.30, score=102.6]; EF-hand domain pair [PF13499.8, score=72.6]; EF hand [PF00036.34, score=64.2]; EF-hand domain pair [PF13833.8, score=51.3]; EF-hand domain [PF13405.8, score=46.1]; EF hand [PF13202.8, score=36.7]; PPP5 TPR repeat region [PF08321.14, score=36.6]; EF-hand domain [PF14658.8, score=26.5]; IQ calmodulin-binding motif [PF00612.29, score=21.3]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.8]} {Human: ENSG00000086717, PPEF1, protein phosphatase with EF-hand domain 1, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000062168, Ppef1, protein phosphatase with EF hand calcium-binding domain 1, [Score=520, Expect=3e-177]} {Dmel: FBgn0265959, rdgC, retinal degeneration C, [Score=529, Expect=2e-180]} {Celegans: WBGene00003969, pef-1, Serine/threonine-protein phosphatase with EF-hands pef-1, [Score=598, Expect=0.0]} {Smed: dd_Smed_v6_11874_0_1, dd_Smed_v6_11874_0_1, [Score=671, Expect=0.0]} {RNA1509_3508} {RNA1310_10928.2} {RNA815_11707} |
42. | MligTC455_42484 | 246 | 5.12 | Mlig455_046416 | Neo: - Age: Down-Up-Down Region-specific R2: 4.313 Region-enriched R2: 2.983/0.00930 |
3.629 | 0.964 | 0.828 | - | 0.943 | 0.894 | - | Mlig455_046416 {REF} {Length: 1006} {RNA1310_40237.1} {RNA815_18246} | |
43. | MligTC455_17562 | 108 | 2.25 | Mlig455_022496 | Neo: - Age: - |
NECAB3 | 3.625 | - | 0.801 | 0.960 | 0.907 | 0.957 | - | Mlig455_022496 {REF} {Length: 1499} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=191, Expect=7e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461} {RNA815_25216} |
44. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 3.617 | 0.973 | 0.840 | 0.959 | - | 0.845 | - | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
45. | MligTC455_51557 | 57 | 1.19 | Mlig455_038195 | Neo: - Age: Down-Up-Up |
ISL1 | 3.612 | 0.938 | - | 0.812 | 0.900 | 0.962 | - | Mlig455_038195 {REF} {Length: 2149} {Pfam: LIM domain [PF00412.24, score=91.4]; Homeodomain [PF00046.31, score=55.3]; Homeobox KN domain [PF05920.13, score=23.4]} {Human: ENSG00000016082, ISL1, ISL LIM homeobox 1, [Score=180, Expect=9e-52]; ENSG00000159556, ISL2, ISL LIM homeobox 2, [Score=173, Expect=3e-49]} {Mouse: ENSMUSG00000042258, Isl1, ISL1 transcription factor, LIM/homeodomain, [Score=180, Expect=6e-52]; ENSMUSG00000032318, Isl2, insulin related protein 2 (islet 2), [Score=175, Expect=4e-50]} {Dmel: FBgn0003896, tup, tailup, [Score=151, Expect=3e-40]} {Celegans: WBGene00002989, lim-7, CeLIM-7; LIM domain family, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8820_0_1, dd_Smed_v6_8820_0_1, [Score=303, Expect=1e-97]} {RNA1310_54855} {RNA815_46288} |
46. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 3.603 | 0.948 | - | 0.976 | 0.739 | 0.940 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
47. | MligTC455_41823 | 300 | 6.25 | Mlig455_022277 | Neo: - Age: - Region-enriched R2: 3.150/0.00185 |
3.6 | - | - | 0.886 | 0.960 | 0.891 | 0.863 | Mlig455_022277 {REF} {Length: 753} {RNA1509_49797} {RNA1310_60350} {RNA815_30999} | |
48. | MligTC455_13421 | 86 | 1.79 | Mlig455_036504, Mlig455_069144 | Neo: - Age: - |
SYT17 | 3.597 | 0.938 | - | 0.831 | 0.876 | 0.952 | - | Mlig455_036504 {REF} {Length: 2390} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} Mlig455_069144 {REF} {Length: 1355} {Pfam: C2 domain [PF00168.32, score=84.3]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=137, Expect=5e-35]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=137, Expect=6e-35]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=101, Expect=1e-22]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=105, Expect=2e-24]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [RH, Score=124, Expect=2e-30]} {RNA1310_17303} {RNA815_33031} |
49. | MligTC455_46022 | 51 | 1.07 | Mlig455_009838 | Neo: - Age: - |
3.596 | 0.812 | - | - | 0.985 | 0.947 | 0.852 | Mlig455_009838 {REF} {Length: 1632} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=54.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.2]} {Dmel: FBgn0038874, ETHR, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_17171_0_1, dd_Smed_v6_17171_0_1, [Score=175, Expect=2e-51]} {RNA1310_62858} {RNA815_33606} | |
50. | MligTC455_17218 | 37 | 0.78 | Mlig455_053853 | Neo: - Age: - |
3.593 | 0.967 | - | 0.913 | 0.867 | 0.846 | - | Mlig455_053853 {REF} {Length: 1743} {RNA1310_61921} | |
51. | MligTC455_16166 | 638 | 13.28 | Mlig455_045546, Mlig455_052637 | Neo: - Age: - |
B3GALT5 | 3.592 | - | 0.983 | - | 0.928 | 0.869 | 0.812 | Mlig455_045546 {REF} {Length: 2520} {Pfam: Galactosyltransferase [PF01762.23, score=159.0]} {Human: ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [RH, Score=129, Expect=2e-32]} {Mouse: ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=113, Expect=5e-27]; ENSMUSG00000074892, B3galt5, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5, [Score=111, Expect=2e-26]; ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=110, Expect=1e-25]} {Dmel: FBgn0035558, CG11357, [RH, Score=147, Expect=3e-38]} {Celegans: WBGene00000270, bre-5, Beta-1,3-galactosyltransferase bre-5, [Score=72.8, Expect=3e-14]} {Smed: dd_Smed_v6_12783_0_1, dd_Smed_v6_12783_0_1, [Score=149, Expect=5e-40]} {RNA1509_45540} {RNA1310_2435} {RNA815_25407} Mlig455_052637 {REF} {Length: 2225} {Pfam: Galactosyltransferase [PF01762.23, score=159.1]} {Human: ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [RH, Score=125, Expect=3e-31]} {Mouse: ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=114, Expect=1e-27]; ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=109, Expect=3e-25]} {Dmel: FBgn0035558, CG11357, [Score=143, Expect=1e-36]} {Celegans: WBGene00000270, bre-5, Beta-1,3-galactosyltransferase bre-5, [Score=71.2, Expect=3e-13]} {Smed: dd_Smed_v6_12783_0_1, dd_Smed_v6_12783_0_1, [Score=152, Expect=3e-41]} {RNA1509_45540} {RNA1310_2435} {RNA815_25407} |
52. | MligTC455_34525 | 52 | 1.08 | Mlig455_021566 | Neo: - Age: Down-Up-Down |
GNAI1 | 3.587 | 0.961 | - | 0.946 | 0.944 | 0.736 | - | Mlig455_021566 {REF} {Length: 3532} {Pfam: G-protein alpha subunit [PF00503.22, score=404.9]; ADP-ribosylation factor family [PF00025.23, score=56.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=20.1]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.4]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=486, Expect=2e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=481, Expect=3e-169]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=474, Expect=1e-166]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=486, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=475, Expect=5e-167]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=474, Expect=1e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=468, Expect=2e-164]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=446, Expect=5e-156]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=598, Expect=0.0]} {RNA1509_45426} {RNA1310_26920, RNA1509_45426} {RNA1509_45426, RNA815_11718} |
53. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 3.579 | 0.966 | 0.786 | 0.930 | - | 0.897 | - | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
54. | MligTC455_44999 | 2214 | 46.12 | Mlig455_067394, Mlig455_069538 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.840/0.00027 |
3.579 | - | 0.712 | 0.951 | 0.978 | 0.938 | - | Mlig455_067394 {REF} {Length: 401} {RNA1509_52966} {RNA1310_68651, RNA1509_52966} {RNA1509_52966, RNA815_33112.1} Mlig455_069538 {REF} {Length: 1759} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=45.8, Expect=1e-06]} {RNA1509_13671} {RNA1310_56061} {RNA815_33112.1} |
|
55. | MligTC455_45414 | 4030 | 83.95 | Mlig455_045096 | Neo: - Age: Down-Down-Up Region-specific R2: 2.245 Region-enriched R2: 1.386/0.00025 Regeneration-depleted TP: -1.938 |
3.577 | - | 0.944 | 0.705 | 0.964 | 0.964 | - | Mlig455_045096 {REF} {Length: 1427} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1310_24092, RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192, RNA815_369.1} | |
56. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
3.576 | - | 0.838 | 0.956 | 0.874 | 0.908 | - | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
57. | MligTC455_04854 | 57 | 1.18 | Mlig455_032030 | Neo: - Age: - Region-enriched R2: 5.099/0.03475 |
3.575 | - | 0.857 | 0.905 | 0.855 | 0.958 | - | Mlig455_032030 {REF} {Length: 1388} {RNA1310_84273} | |
58. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
3.572 | 0.954 | - | 0.951 | 0.894 | 0.773 | - | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
59. | MligTC455_44354 | 1240 | 25.82 | Mlig455_001577 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.349 Region-specific R2: 5.143 Region-enriched R2: 4.498/0.00000 Regeneration-downregulated R2: -2.807 Regeneration-depleted R2: -2.807 |
3.572 | - | 0.852 | 0.838 | 0.964 | 0.918 | - | Mlig455_001577 {REF} {Length: 1028} {RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1310_49541.2, RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1509_23470, RNA1509_33941, RNA1509_57202, RNA815_59782} | |
60. | MligTC455_42784 | 842 | 17.55 | Mlig455_004621, Mlig455_004630, Mlig455_004657 | Neo: - Age: - Region-enriched R2: 2.895/0.00752 |
3.571 | - | 0.853 | 0.810 | 0.926 | 0.982 | - | Mlig455_004621 {REF} {Length: 1246} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1} {RNA815_16689.1} Mlig455_004630 {REF} {Length: 2167} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.2} {RNA815_16689.1} Mlig455_004657 {REF} {Length: 1250} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1} {RNA815_16689.1} |
|
61. | MligTC455_41854 | 80 | 1.67 | Mlig455_034307, Mlig455_067305, Mlig455_067321 | Neo: - Age: - |
3.564 | 0.961 | 0.751 | - | 0.936 | 0.916 | - | Mlig455_034307 {REF} {Length: 459} {RNA815_51696.1} Mlig455_067305 {REF} {Length: 466} {RNA815_51696.1} Mlig455_067321 {REF} {Length: 95} {TRANSSPLICED} {NoTransDecoderORF} {RNA815_51696.1} |
|
62. | MligTC455_47601 | 126 | 2.62 | Mlig455_056477 | Neo: - Age: Up-Down-Up |
NRXN1 | 3.561 | 0.832 | 0.854 | 0.924 | - | 0.951 | - | Mlig455_056477 {REF} {Length: 3481} {Pfam: Laminin G domain [PF02210.26, score=58.3]; Laminin G domain [PF00054.25, score=43.2]; Syndecan domain [PF01034.22, score=27.4]} {Human: ENSG00000179915, NRXN1, neurexin 1, [Score=142, Expect=4e-35]} {Mouse: ENSMUSG00000024109, Nrxn1, neurexin I, [Score=142, Expect=1e-35]} {Dmel: FBgn0038975, Nrx-1, Neurexin 1, [Score=102, Expect=2e-22]} {Smed: dd_Smed_v6_13697_0_1, dd_Smed_v6_13697_0_1, [Score=142, Expect=8e-36]} {RNA1509_55888} {RNA1310_37025, RNA1509_55888} {RNA1509_55888, RNA815_22404} |
63. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
3.56 | - | 0.989 | 0.820 | 0.831 | 0.920 | - | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
64. | MligTC455_12126 | 26 | 0.55 | Mlig455_040946 | Neo: - Age: - |
3.557 | - | 0.791 | 0.961 | 0.908 | 0.897 | - | Mlig455_040946 {REF} {Length: 1894} {RNA1310_146540} {RNA815_59956} | |
65. | MligTC455_29914 | 44 | 0.91 | Mlig455_027923 | Neo: - Age: Down-Up-Down Region-enriched R2: 8.096/0.00455 |
ANGPTL3 | 3.553 | 0.963 | 0.777 | 0.919 | 0.894 | - | - | Mlig455_027923 {REF} {Length: 1663} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=70.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=60.5, Expect=9e-10]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=59.3, Expect=2e-09]; ENSG00000120332, TNN, tenascin N, [Score=58.9, Expect=3e-09]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=62.4, Expect=2e-10]} {Dmel: FBgn0031804, CG9500, [Score=76.3, Expect=6e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=51.2, Expect=3e-07]} {RNA1509_53291} {RNA1310_58974} {RNA815_43288.3} |
66. | MligTC455_33040 | 203 | 4.23 | Mlig455_032497 | Neo: - Age: logFC(26M/2M)=0.515 Region-enriched R2: 4.005/0.00408 |
PKD2L1 | 3.551 | 0.936 | 0.960 | 0.950 | 0.705 | - | - | Mlig455_032497 {REF} {Length: 3318} {Pfam: Polycystin cation channel [PF08016.14, score=293.1]; Ion transport protein [PF00520.33, score=39.7]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=236, Expect=4e-66]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=261, Expect=3e-73]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=131, Expect=5e-31]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=180, Expect=1e-47]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=641, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
67. | MligTC455_20028 | 492 | 10.25 | Mlig455_060293, Mlig455_065638 | Neo: - Age: logFC(26M/2M)=-0.541 Region-enriched R2: 1.959/0.01794 |
LRRC55 | 3.55 | - | 0.851 | 0.864 | 0.869 | 0.966 | - | Mlig455_060293 {REF} {Length: 2403} {Pfam: Leucine rich repeat [PF13855.8, score=64.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=21.3]} {Human: ENSG00000183908, LRRC55, leucine rich repeat containing 55, [Score=59.7, Expect=4e-09]; ENSG00000171236, LRG1, leucine rich alpha-2-glycoprotein 1, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000075224, Lrrc55, leucine rich repeat containing 55, [Score=58.5, Expect=6e-09]; ENSMUSG00000020105, Lrig3, leucine-rich repeats and immunoglobulin-like domains 3, [Score=57.0, Expect=4e-08]} {Dmel: FBgn0033250, CG14762, [Score=63.2, Expect=2e-10]} {RNA1509_43260} {RNA1310_15302, RNA1509_43260} {RNA1509_43260, RNA815_13279} Mlig455_065638 {REF} {Length: 2056} {Pfam: Leucine rich repeat [PF13855.8, score=62.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=21.6]} {Human: ENSG00000183908, LRRC55, leucine rich repeat containing 55, [Score=61.2, Expect=1e-09]} {Mouse: ENSMUSG00000075224, Lrrc55, leucine rich repeat containing 55, [Score=60.1, Expect=2e-09]} {Dmel: FBgn0033250, CG14762, [Score=62.4, Expect=5e-10]} {RNA1509_43260} {RNA1310_15302} {RNA815_13279} |
68. | MligTC455_25920 | 378 | 7.87 | Mlig455_006540 | Neo: - |
3.541 | 0.928 | 0.743 | - | 0.899 | 0.971 | - | Mlig455_006540 {REF} {Length: 1697} {RNA1509_12380} {RNA1310_42539} {RNA815_19957} | |
69. | MligTC455_25914 | 4684 | 97.58 | Mlig455_004975 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.418 Region-enriched R2: 1.471/0.00163 Regeneration-downregulated BL: -1.843 Regeneration-depleted BL: -1.843 |
3.54 | - | 0.851 | 0.810 | 0.915 | 0.964 | - | Mlig455_004975 {REF} {Length: 5220} {RNA1509_1158, RNA1509_11723} {RNA1310_4621.1, RNA1509_11723} {RNA1509_11723, RNA815_1336.1} | |
70. | MligTC455_45080 | 3677 | 76.61 | Mlig455_021478, Mlig455_062024, Mlig455_063226, Mlig455_067363 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.291 Region-enriched R8: 1.930/0.00003 |
3.536 | - | 0.879 | - | 0.951 | 0.900 | 0.806 | Mlig455_021478 {REF} {Length: 753} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_062024 {REF} {Length: 752} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_063226 {REF} {Length: 753} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_067363 {REF} {Length: 767} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} |
|
71. | MligTC455_18602 | 116 | 2.42 | Mlig455_003494 | Neo: - Age: - |
KCTD21 | 3.535 | 0.917 | 0.964 | 0.862 | - | 0.792 | - | Mlig455_003494 {REF} {Length: 3275} {Pfam: BTB/POZ domain [PF02214.24, score=65.0]} {Human: ENSG00000188997, KCTD21, potassium channel tetramerization domain containing 21, [Score=88.6, Expect=3e-21]; ENSG00000183783, KCTD8, potassium channel tetramerization domain containing 8, [Score=87.8, Expect=7e-19]} {Mouse: ENSMUSG00000044952, Kctd21, potassium channel tetramerisation domain containing 21, [Score=87.8, Expect=5e-20]; ENSMUSG00000037653, Kctd8, potassium channel tetramerisation domain containing 8, [Score=85.9, Expect=2e-18]} {Dmel: FBgn0038839, Ktl, Kctd12-like, [Score=82.0, Expect=3e-18]} {Celegans: WBGene00014848, VM106R.1, [Score=77.4, Expect=4e-16]} {Smed: dd_Smed_v6_8654_0_1, dd_Smed_v6_8654_0_1, [Score=89.0, Expect=8e-21]} {RNA1310_21779.1} {RNA815_18356} |
72. | MligTC455_02855 | 144 | 3 | Mlig455_000237 | Neo: - Age: - |
B3GALT2 | 3.531 | - | 0.791 | 0.811 | 0.961 | 0.968 | - | Mlig455_000237 {REF} {Length: 757} {Pfam: Galactosyltransferase [PF01762.23, score=48.0]} {Human: ENSG00000162630, B3GALT2, beta-1,3-galactosyltransferase 2, [Score=48.5, Expect=8e-07]} {Mouse: ENSMUSG00000033849, B3galt2, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2, [Score=48.5, Expect=6e-07]} {Dmel: FBgn0035558, CG11357, [Score=61.6, Expect=1e-11]} {Smed: dd_Smed_v6_4748_0_1, dd_Smed_v6_4748_0_1, [Score=88.2, Expect=2e-21]} {RNA1509_17403} {RNA1310_48383} {RNA815_28728} |
73. | MligTC455_43524 | 172 | 3.58 | Mlig455_031179 | Neo: - Age: - Region-enriched R2: 3.416/0.00534 |
SLC30A2 | 3.531 | - | 0.839 | 0.807 | 0.923 | 0.962 | - | Mlig455_031179 {REF} {Length: 2311} {Pfam: Cation efflux family [PF01545.23, score=155.3]; Dimerisation domain of Zinc Transporter [PF16916.7, score=21.1]} {Human: ENSG00000158014, SLC30A2, solute carrier family 30 member 2, [Score=350, Expect=3e-117]} {Mouse: ENSMUSG00000028836, Slc30a2, solute carrier family 30 (zinc transporter), member 2, [Score=362, Expect=3e-122]} {Dmel: FBgn0028516, ZnT35C, Zinc transporter 35C, [RH, Score=324, Expect=1e-106]} {Celegans: WBGene00011821, cdf-2, Cation Diffusion Facilitator family, [RH, Score=324, Expect=7e-108]} {Smed: dd_Smed_v6_5529_0_1, dd_Smed_v6_5529_0_1, [Score=432, Expect=4e-150]} {RNA1509_37229} {RNA1310_13324.1} {RNA815_5520} |
74. | MligTC455_22323 | 68 | 1.42 | Mlig455_000713, Mlig455_000766 | Neo: - Age: - |
HCN4 | 3.529 | 0.915 | - | 0.965 | 0.725 | 0.924 | - | Mlig455_000713 {REF} {Length: 3555} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.6]; Cyclic nucleotide-binding domain [PF00027.31, score=70.8]; Ion transport protein [PF00520.33, score=62.7]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=581, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=568, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=579, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=563, Expect=0.0]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [RH, Score=512, Expect=1e-161]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=859, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} Mlig455_000766 {REF} {Length: 4037} {Pfam: Ion transport protein N-terminal [PF08412.12, score=83.5]; Cyclic nucleotide-binding domain [PF00027.31, score=70.7]; Ion transport protein [PF00520.33, score=62.6]} {Human: ENSG00000138622, HCN4, hyperpolarization activated cyclic nucleotide gated potassium channel 4, [Score=566, Expect=0.0]; ENSG00000099822, HCN2, hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, [Score=553, Expect=0.0]} {Mouse: ENSMUSG00000032338, Hcn4, hyperpolarization-activated, cyclic nucleotide-gated K+ 4, [Score=564, Expect=0.0]; ENSMUSG00000020331, Hcn2, hyperpolarization-activated, cyclic nucleotide-gated K+ 2, [Score=548, Expect=3e-180]} {Dmel: FBgn0263397, Ih, I[[h]] channel, [Score=502, Expect=4e-166]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=133, Expect=8e-32]} {Smed: dd_Smed_v6_16523_0_1, dd_Smed_v6_16523_0_1, [Score=844, Expect=0.0]} {RNA1509_59211} {RNA1310_33761} {RNA815_15561.1} |
75. | MligTC455_49342 | 107 | 2.23 | Mlig455_051342 | Neo: - Age: - |
3.526 | 0.830 | 0.779 | 0.946 | 0.971 | - | - | Mlig455_051342 {REF} {Length: 2549} {RNA1509_48157} {RNA1310_19014, RNA1509_48157} {RNA1509_48157, RNA815_10014.1} | |
76. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
3.524 | 0.839 | 0.964 | 0.951 | 0.770 | - | - | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
77. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 3.522 | - | 0.922 | 0.925 | 0.959 | 0.716 | - | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
78. | MligTC455_25915 | 4499 | 93.72 | Mlig455_005297 | Neo: - Age: - Region-enriched R2: 1.495/0.00336 Regeneration-downregulated BL: -1.833 Regeneration-depleted BL: -1.833 |
CPE | 3.517 | - | 0.854 | 0.781 | 0.917 | 0.965 | - | Mlig455_005297 {REF} {Length: 3239} {Pfam: Zinc carboxypeptidase [PF00246.26, score=188.0]; Carboxypeptidase regulatory-like domain [PF13620.8, score=23.3]} {Human: ENSG00000109472, CPE, carboxypeptidase E, [Score=322, Expect=8e-105]} {Mouse: ENSMUSG00000037852, Cpe, carboxypeptidase E, [Score=318, Expect=1e-103]} {Dmel: FBgn0004648, svr, silver, [Score=225, Expect=2e-68]} {Celegans: WBGene00001189, egl-21, Carboxypeptidase E, [RH, Score=333, Expect=5e-110]} {Smed: dd_Smed_v6_3059_0_1, dd_Smed_v6_3059_0_1, [RH, Score=384, Expect=7e-130]} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1310_4621.1, RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908, RNA815_1336.1} |
79. | MligTC455_18607 | 203 | 4.23 | Mlig455_012344, Mlig455_012722 | Neo: - Age: - Region-enriched R2: 3.338/0.02204 |
ANKRD63 | 3.516 | - | 0.748 | 0.870 | 0.966 | 0.932 | - | Mlig455_012344 {REF} {Length: 1989} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.3]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=55.5, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_1, dd_Smed_v6_11187_0_1, [Score=59.3, Expect=2e-09]} {RNA1310_37830} {RNA815_38436} Mlig455_012722 {REF} {Length: 2256} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.2]; Ankyrin repeats (many copies) [PF13637.8, score=67.3]; Ankyrin repeat [PF00023.32, score=56.6]; Ankyrin repeats (many copies) [PF13857.8, score=50.3]; Ankyrin repeat [PF13606.8, score=47.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [RH, Score=129, Expect=1e-33]} {Dmel: FBgn0031473, CG3104, [Score=54.7, Expect=5e-08]} {Celegans: WBGene00006882, vab-19, VAB-19, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_11187_0_2, dd_Smed_v6_11187_0_2, [Score=59.7, Expect=1e-09]} {RNA1310_37830} {RNA815_38436} |
80. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 3.513 | - | 0.721 | 0.972 | 0.874 | 0.946 | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
81. | MligTC455_43454 | 36 | 0.74 | Mlig455_043999 | Neo: - Age: - |
3.512 | 0.949 | 0.706 | - | 0.891 | 0.966 | - | Mlig455_043999 {REF} {Length: 2456} {Dmel: FBgn0259222, CG42322, [RH, Score=101, Expect=3e-22]} {Smed: dd_Smed_v6_18554_0_1, dd_Smed_v6_18554_0_1, [Score=82.4, Expect=1e-17]} {RNA1310_20749} {RNA815_38231} | |
82. | MligTC455_43642 | 2199 | 45.81 | Mlig455_018475 | Neo: - Age: Down-Up-Up Region-specific R2: 2.701 Region-enriched R2: 2.110/0.00000 |
3.508 | 0.779 | - | 0.898 | 0.869 | 0.962 | - | Mlig455_018475 {REF} {Length: 949} {RNA1509_30521} {RNA1310_47277.3, RNA1509_30521} {RNA1509_30521, RNA815_19145.1} | |
83. | MligTC455_40782 | 1513 | 31.52 | Mlig455_021202 | Neo: - Age: Up-Down-Up Region-specific R2: 2.950 Region-enriched R2: 1.950/0.00004 Regeneration-downregulated BL: -2.428 Regeneration-depleted BL: -2.428 |
3.507 | - | 0.820 | - | 0.973 | 0.871 | 0.843 | Mlig455_021202 {REF} {Length: 2276} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} | |
84. | MligTC455_45134 | 9943 | 207.14 | Mlig455_022505 | Neo: - Age: - Region-enriched R2: 1.329/0.00560 Regeneration-downregulated BL: -1.932 Regeneration-depleted BL: -1.932 |
PAM | 3.506 | - | 0.851 | 0.789 | 0.916 | 0.950 | - | Mlig455_022505 {REF} {Length: 1757} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=107.0]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=69.2]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=190, Expect=4e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=186, Expect=7e-53]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [Score=219, Expect=5e-69]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [Score=224, Expect=8e-72]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [Score=255, Expect=4e-83]} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1310_15063.1, RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118, RNA815_4981} |
85. | MligTC455_28695 | 95 | 1.98 | Mlig455_033490 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.072/0.04773 |
PLCH2 | 3.501 | 0.945 | 0.744 | 0.970 | 0.842 | - | - | Mlig455_033490 {REF} {Length: 13918} {tRNA: Undet(NNN),pseudo, score=20.5} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=199.7]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=104.2]; RasGEF domain [PF00617.21, score=53.7]; Ras association (RalGDS/AF-6) domain [PF00788.25, score=44.8]; FERM central domain [PF00373.20, score=29.5]; C2 domain [PF00168.32, score=27.4]; Ankyrin repeat [PF00023.32, score=22.4]; Ankyrin repeats (3 copies) [PF12796.9, score=21.4]} {Human: ENSG00000276429, PLCH2, phospholipase C eta 2, [Score=325, Expect=2e-89]; ENSG00000149527, PLCH2, phospholipase C eta 2, [Score=325, Expect=2e-89]} {Mouse: ENSMUSG00000024998, Plce1, phospholipase C, epsilon 1, [RH, Score=281, Expect=4e-75]} {Dmel: FBgn0003416, sl, small wing, [Score=167, Expect=1e-40]} {Celegans: WBGene00004036, plc-1, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1, [Score=248, Expect=3e-65]} {Smed: dd_Smed_v6_9716_1_1, dd_Smed_v6_9716_1_1, [RH, Score=739, Expect=0.0]} {RNA1509_26054} {RNA1310_1143.2, RNA1509_26054} {RNA1509_26054, RNA815_10233} |
86. | MligTC455_25073 | 1271 | 26.47 | Mlig455_015905 | Neo: - Age: logFC(26M/2M)=-0.947 Region-specific R2: 3.291 Region-enriched R2: 2.110/0.00052 |
PI16 | 3.5 | 0.847 | 0.807 | - | 0.964 | 0.882 | - | Mlig455_015905 {REF} {Length: 2189} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=111, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=7e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.1, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=3e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_36129, RNA1509_46021, RNA1509_5027} {RNA1310_1356.1, RNA1509_36129, RNA1509_46021} {RNA1509_36129, RNA1509_46021, RNA815_4508} |
87. | MligTC455_33287 | 444 | 9.24 | Mlig455_061811 | Neo: - Age: - Region-enriched R2: 4.031/0.00004 |
3.5 | 0.849 | - | 0.888 | 0.951 | 0.812 | - | Mlig455_061811 {REF} {Length: 782} {RNA1509_48963} {RNA1310_53012} {RNA815_23468} | |
88. | MligTC455_44329 | 510 | 10.62 | Mlig455_026184, Mlig455_026199 | Neo: - Age: - Region-specific R2: 5.127 Region-enriched R2: 4.824/0.00000 |
3.499 | - | 0.885 | 0.767 | 0.964 | 0.883 | - | Mlig455_026184 {REF} {Length: 724} {RNA1509_29216, RNA1509_32102} {RNA1310_60068, RNA1509_29216} {RNA1509_29216, RNA815_37486} Mlig455_026199 {REF} {Length: 531} {RNA1509_32102} {RNA1310_60068} {RNA815_37486} |
|
89. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
3.497 | 0.948 | 0.790 | 0.956 | - | 0.803 | - | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
90. | MligTC455_45020 | 386 | 8.05 | Mlig455_012422 | Neo: - Age: - Region-enriched R2: 4.067/0.00066 |
AVP | 3.496 | 0.745 | - | 0.954 | 0.931 | 0.866 | - | Mlig455_012422 {REF} {Length: 1252} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.0]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=50.4, Expect=4e-08]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=52.0, Expect=7e-09]} {RNA1509_50574} {RNA1310_26737, RNA1509_50574} {RNA1509_50574, RNA815_23813} |
91. | MligTC455_08333 | 172 | 3.59 | Mlig455_025435, Mlig455_025445 | Neo: - Age: - |
TNS1 | 3.49 | - | 0.814 | 0.838 | 0.880 | 0.958 | - | Mlig455_025435 {REF} {Length: 4797} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=67.1]; C2 domain of PTEN tumour-suppressor protein [PF10409.11, score=38.4]; SH2 domain [PF00017.26, score=36.5]} {Human: ENSG00000079308, TNS1, tensin 1, [RH, Score=257, Expect=2e-69]; ENSG00000136205, TNS3, tensin 3, [RH, Score=251, Expect=1e-67]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [RH, Score=256, Expect=1e-72]; ENSMUSG00000020422, Tns3, tensin 3, [RH, Score=251, Expect=1e-67]} {Dmel: FBgn0000244, by, blistery, [RH, Score=222, Expect=2e-60]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=243, Expect=6e-72]} {Smed: dd_Smed_v6_4454_0_2, dd_Smed_v6_4454_0_2, [Score=217, Expect=5e-59]} {RNA1509_43365} {RNA1310_7714, RNA1509_43365} {RNA1509_43365, RNA815_14514} Mlig455_025445 {REF} {Length: 1758} {Pfam: C2 domain of PTEN tumour-suppressor protein [PF10409.11, score=37.0]} {Human: ENSG00000079308, TNS1, tensin 1, [RH, Score=191, Expect=2e-53]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=191, Expect=3e-51]; ENSMUSG00000037003, Tns2, tensin 2, [Score=187, Expect=4e-50]} {Dmel: FBgn0026379, Pten, Phosphatase and tensin homolog, [Score=67.8, Expect=1e-11]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=109, Expect=1e-24]} {RNA1509_44169} {RNA1310_10509} {RNA815_24170} |
92. | MligTC455_48720 | 1367 | 28.48 | Mlig455_017034 | Neo: - Age: - Region-specific R2: 4.593 Region-enriched R2: 3.164/0.00157 |
3.488 | - | 0.967 | - | 0.759 | 0.919 | 0.843 | Mlig455_017034 {REF} {Length: 866} {RNA1509_17554, RNA1509_28146} {RNA1310_40772, RNA1509_28146} {RNA1509_28146, RNA815_29897} | |
93. | MligTC455_46982 | 256 | 5.34 | Mlig455_044826 | Neo: - Age: - |
SYN3 | 3.486 | - | - | 0.852 | 0.896 | 0.952 | 0.786 | Mlig455_044826 {REF} {Length: 2562} {TRANSSPLICED} {Pfam: Synapsin, ATP binding domain [PF02750.16, score=168.9]} {Human: ENSG00000185666, SYN3, synapsin III, [RH, Score=176, Expect=7e-53]} {Mouse: ENSMUSG00000059602, Syn3, synapsin III, [Score=173, Expect=2e-49]; ENSMUSG00000037217, Syn1, synapsin I, [Score=170, Expect=6e-48]} {Dmel: FBgn0004575, Syn, Synapsin, [Score=186, Expect=1e-54]} {Celegans: WBGene00004913, snn-1, SyNapsiN; Synapsin, [Score=105, Expect=6e-26]} {Smed: dd_Smed_v6_3135_0_2, dd_Smed_v6_3135_0_2, [RH, Score=216, Expect=3e-68]} {RNA1310_32498} {RNA815_34432} |
94. | MligTC455_21598 | 204 | 4.24 | Mlig455_025053, Mlig455_066017 | Neo: - Age: - |
3.482 | 0.967 | 0.832 | 0.917 | 0.766 | - | - | Mlig455_025053 {REF} {Length: 2703} {Pfam: Innexin [PF00876.20, score=416.1]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=94.0, Expect=7e-21]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=324, Expect=8e-108]} {Smed: dd_Smed_v6_6114_0_1, dd_Smed_v6_6114_0_1, [RH, Score=539, Expect=0.0]} {RNA1509_7709} {RNA1310_34948} {RNA815_31035} Mlig455_066017 {REF} {Length: 2311} {Pfam: Innexin [PF00876.20, score=372.0]} {Dmel: FBgn0085387, shakB, shaking B, [Score=81.3, Expect=2e-16]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=286, Expect=6e-94]} {Smed: dd_Smed_v6_6114_0_3, dd_Smed_v6_6114_0_3, [Score=446, Expect=4e-155]} {RNA1509_7709} {RNA1310_34948} {RNA815_4210.1} |
|
95. | MligTC455_15694 | 54 | 1.13 | Mlig455_026426, Mlig455_026456 | Neo: - Age: - Region-enriched R2: 6.151/0.00957 |
SSTR1 | 3.48 | 0.892 | 0.871 | 0.766 | - | 0.951 | - | Mlig455_026426 {REF} {Length: 2191} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.7]; Olfactory receptor [PF13853.8, score=26.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.2]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=6e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=4e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=5e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=111, Expect=1e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=2e-33]} {RNA1310_38996} {RNA815_25059} Mlig455_026456 {REF} {Length: 2423} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=26.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.3]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=5e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=3e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=7e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=110, Expect=2e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=1e-33]} {RNA1310_38996} {RNA815_25059} |
96. | MligTC455_44904 | 1501 | 31.27 | Mlig455_021814 | Neo: - Age: Down-Up-Up Region-specific R2: 3.865 Region-enriched R2: 3.792/0.00000 |
3.475 | - | 0.812 | 0.737 | 0.963 | 0.963 | - | Mlig455_021814 {REF} {Length: 959} {RNA1509_15805} {RNA1310_67099.1, RNA1509_15805} {RNA1509_15805, RNA815_17533} | |
97. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
3.475 | 0.717 | - | 0.922 | 0.885 | 0.951 | - | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
98. | MligTC455_19567 | 76 | 1.59 | Mlig455_017855, Mlig455_047877 | Neo: - Age: - Region-enriched R2: 7.793/0.00005 |
3.468 | - | 0.739 | 0.936 | 0.966 | 0.827 | - | Mlig455_017855 {REF} {Length: 1874} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.0]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [RH, Score=179, Expect=3e-51]} {RNA1509_52053} {RNA1310_13207} {RNA815_13534} Mlig455_047877 {REF} {Length: 1820} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=28.8]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [RH, Score=179, Expect=2e-51]} {RNA1509_52053} {RNA1310_13207} {RNA815_13534} |
|
99. | MligTC455_42785 | 79 | 1.65 | Mlig455_004724 | Neo: - Age: Down-Up-Down |
3.455 | - | 0.968 | 0.729 | 0.767 | 0.991 | - | Mlig455_004724 {REF} {Length: 1460} {NoTransDecoderORF} {RNA1509_29447} {RNA1310_33893.1, RNA1509_29447} {RNA1509_29447, RNA815_16689.1} | |
100. | MligTC455_51790 | 524 | 10.92 | Mlig455_012435, Mlig455_012564 | Neo: - Age: - Region-enriched R2: 2.233/0.04465 Regeneration-downregulated BL: -4.065 Regeneration-depleted BL: -4.065 |
PRKAR2A | 3.453 | - | 0.876 | - | 0.958 | 0.766 | 0.853 | Mlig455_012435 {REF} {Length: 1982} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=139.6]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=50.9]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [RH, Score=380, Expect=6e-130]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [RH, Score=397, Expect=6e-137]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [RH, Score=407, Expect=4e-141]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=216, Expect=1e-66]} {Smed: dd_Smed_v6_2902_0_1, dd_Smed_v6_2902_0_1, [RH, Score=457, Expect=2e-161]} {RNA1509_20187} {RNA1310_20991} {RNA815_24093} Mlig455_012564 {REF} {Length: 1980} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=139.6]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=50.9]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [RH, Score=380, Expect=6e-130]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [RH, Score=397, Expect=6e-137]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [RH, Score=407, Expect=4e-141]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=216, Expect=1e-66]} {Smed: dd_Smed_v6_2902_0_1, dd_Smed_v6_2902_0_1, [RH, Score=457, Expect=2e-161]} {RNA1509_20187} {RNA1310_20991} {RNA815_24093} |